Cargando...
Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab
BACKGROUND: Immune checkpoint inhibition has dramatically transformed the treatment of malignant melanoma. With increasing use, their unique spectrum of immune-mediated toxicity has become apparent. CASE PRESENTATION: We describe a case of sequential immune-related adverse events (irAEs) in a patien...
Guardado en:
| Publicado en: | J Immunother Cancer |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6740018/ https://ncbi.nlm.nih.gov/pubmed/31511075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0727-5 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|